IDEXX Financial Statements From 2010 to 2024

Stocks . UK . 
Stock . IDEXX Laboratories
0J8P Stock   431.44  1.10  0.25%   
IDEXX Laboratories financial statements provide useful quarterly and yearly information to potential IDEXX Laboratories investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on IDEXX Laboratories financial statements helps investors assess IDEXX Laboratories' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting IDEXX Laboratories' valuation are summarized below:
Gross Profit
2 B
Profit Margin
0.2253
Market Capitalization
3.7 T
Revenue
3.8 B
Earnings Share
8.517
There are over seventy-nine available fundamental trends for IDEXX Laboratories, which can be analyzed over time and compared to other ratios. All traders should confirm IDEXX Laboratories' regular fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

IDEXX Laboratories Total Revenue

3.84 Billion

Check IDEXX Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IDEXX Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 120.7 M, Total Revenue of 3.8 B or Gross Profit of 2.3 B, as well as many indicators such as . IDEXX financial statements analysis is a perfect complement when working with IDEXX Laboratories Valuation or Volatility modules.
  
This module can also supplement various IDEXX Laboratories Technical models . Check out the analysis of IDEXX Laboratories Correlation against competitors.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

IDEXX Laboratories Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.4 B3.3 B1.8 B
Slightly volatile
Other Current Liabilities391 M372.4 M238.7 M
Slightly volatile
Total Current Liabilities999.1 M951.5 M731.6 M
Slightly volatile
Property Plant And Equipment Net858.6 M817.7 M437.8 M
Slightly volatile
Accounts Payable116.2 M110.6 M66.6 M
Slightly volatile
Cash476.6 M453.9 M218.4 M
Slightly volatile
Non Current Assets Total1.9 B1.8 B956.5 M
Slightly volatile
Non Currrent Assets Other349.6 M333 M189.1 M
Slightly volatile
Cash And Short Term Investments476.6 M453.9 M267.4 M
Slightly volatile
Net Receivables556 M529.5 M278 M
Slightly volatile
Common Stock Shares Outstanding94.9 M84 M93.7 M
Slightly volatile
Liabilities And Stockholders Equity3.4 B3.3 B1.8 B
Slightly volatile
Inventory399.3 M380.3 M205.2 M
Slightly volatile
Other Current Assets75.1 M131.5 M99.2 M
Slightly volatile
Total Liabilities1.9 B1.8 B1.4 B
Slightly volatile
Total Current Assets1.6 B1.5 B846 M
Slightly volatile
Intangible Assets66.7 M84.5 M60.9 M
Slightly volatile
Short and Long Term Debt Total1.1 B1.1 B852.1 M
Slightly volatile
Short Term Debt212.2 M344.8 M353 M
Pretty Stable
Common Stock9.2 M10.8 M9.9 M
Slightly volatile
Short Term Investments343.2 M326.9 M247.3 M
Slightly volatile
Current Deferred Revenue25 M37.2 M30 M
Slightly volatile
Good Will218.6 M366 M221.9 M
Slightly volatile
Other Assets1.091.15108.9 M
Pretty Stable
Other Liabilities115.4 M95.9 M144.9 M
Slightly volatile
Long Term Debt711.1 M891.5 M607.1 M
Slightly volatile
Capital Surpluse1.3 B1.5 B1.2 B
Slightly volatile
Deferred Long Term Liabilities115.7 M137.9 M89.2 M
Slightly volatile
Property Plant Equipment648.6 M883.3 M514.9 M
Slightly volatile

IDEXX Laboratories Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization120.7 M114.9 M77.6 M
Slightly volatile
Total Revenue3.8 B3.7 B2.1 B
Slightly volatile
Gross Profit2.3 B2.2 B1.2 B
Slightly volatile
Other Operating Expenses2.7 B2.6 B1.6 B
Slightly volatile
Operating Income1.2 B1.1 B527.3 M
Slightly volatile
EBIT1.2 B1.1 B529.9 M
Slightly volatile
EBITDA1.3 B1.2 B607.6 M
Slightly volatile
Cost Of Revenue1.5 B1.5 B913.7 M
Slightly volatile
Total Operating Expenses1.1 B1.1 B702.8 M
Slightly volatile
Income Before Tax1.1 B1.1 B504.3 M
Slightly volatile
Net Income887.3 M845 M395.5 M
Slightly volatile
Income Tax Expense226.9 M216.1 M108.7 M
Slightly volatile
Research Development200.5 M191 M124.1 M
Slightly volatile
Selling General Administrative187 M335.8 M214.4 M
Slightly volatile
Selling And Marketing Expenses292 M566.1 M339.1 M
Slightly volatile
Interest Expense43.7 M41.6 M23.9 M
Slightly volatile
Tax Provision109.4 M181.5 M103.6 M
Slightly volatile
Interest Income25.3 M26.4 M30.9 M
Slightly volatile
Net Income Applicable To Common Shares563.5 M781 M417.3 M
Slightly volatile
Minority Interest440.8 K813 K407.9 K
Slightly volatile

IDEXX Laboratories Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow129 M112.5 M175.3 M
Very volatile
Depreciation120.7 M114.9 M77.6 M
Slightly volatile
Capital Expenditures140.3 M133.6 M98 M
Slightly volatile
Total Cash From Operating Activities951.8 M906.5 M435 M
Slightly volatile
Net Income887.3 M845 M395.6 M
Slightly volatile
End Period Cash Flow476.6 M453.9 M218.4 M
Slightly volatile
Stock Based Compensation62.7 M59.7 M29 M
Slightly volatile
Change To Netincome31.1 M29.4 M24 M
Slightly volatile

IDEXX Fundamental Market Drivers

Cash And Short Term Investments453.9 M

About IDEXX Laboratories Financial Statements

IDEXX Laboratories shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although IDEXX Laboratories investors may analyze each financial statement separately, they are all interrelated. The changes in IDEXX Laboratories' assets and liabilities, for example, are also reflected in the revenues and expenses on on IDEXX Laboratories' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue37.2 M25 M
Total Revenue3.7 B3.8 B
Cost Of Revenue1.5 B1.5 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
GMGeneral Motors
FFord Motor

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY